Literature DB >> 12226716

Enzymatic production of cyclodextrins.

A Biwer1, G Antranikian, E Heinzle.   

Abstract

Cyclodextrins (CD) are enzymatically modified starches with a wide range of applications in food, pharmaceutical and chemical industries, agriculture and environmental engineering. They are produced from starch via enzymatic conversion using cyclodextrin glycosyl transferases (CGTases) and partly alpha-amylases. Due to its low solubility in water, separation and purification of beta-CD is relatively easy compared to alpha- and gamma-CD. In recent years more economic processes for gamma-CD and especially alpha-CD production have been developed using improved CGTases and downstream processing. New purification steps, e.g. affinity adsorption, may reduce the use of complexing agents. The implementation of thermostable CGTases can simplify the production process and increase the selectivity of the reaction. A tabular overview of alpha-CD production processes is presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226716     DOI: 10.1007/s00253-002-1057-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  39 in total

1.  Glycemic Response to Corn Starch Modified with Cyclodextrin Glycosyltransferase and its Relationship to Physical Properties.

Authors:  A Dura; W Yokoyama; C M Rosell
Journal:  Plant Foods Hum Nutr       Date:  2016-09       Impact factor: 3.921

2.  Structural elucidation of the cyclization mechanism of α-1,6-glucan by Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase.

Authors:  Nobuhiro Suzuki; Zui Fujimoto; Young-Min Kim; Mitsuru Momma; Naomi Kishine; Ryuichiro Suzuki; Shiho Suzuki; Shinichi Kitamura; Mikihiko Kobayashi; Atsuo Kimura; Kazumi Funane
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

3.  Improved activity of β-cyclodextrin glycosyltransferase from Bacillus sp. N-227 via mutagenesis of the conserved residues.

Authors:  Hua Wang; Wenxi Zhou; Hua Li; Bu Rie; Chunhong Piao
Journal:  3 Biotech       Date:  2017-06-08       Impact factor: 2.406

Review 4.  Biosafe nanoscale pharmaceutical adjuvant materials.

Authors:  Shubin Jin; Shengliang Li; Chongxi Wang; Juan Liu; Xiaolong Yang; Paul C Wang; Xin Zhang; Xing-Jie Liang
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

5.  X-ray crystallographic analyses of pig pancreatic alpha-amylase with limit dextrin, oligosaccharide, and alpha-cyclodextrin.

Authors:  Steven B Larson; John S Day; Alexander McPherson
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

6.  Improvement of cyclodextrin glycosyltransferase gene expression in Escherichia coli by insertion of regulatory sequences involved in the promotion of RNA transcription.

Authors:  Norhayati Ramli; Suraini Abd-Aziz; Noorjahan Banu Alitheen; Mohd Ali Hassan; Toshinari Maeda
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

7.  Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781.

Authors:  Haitao Yang; Michael A Parniak; Charles E Isaacs; Sharon L Hillier; Lisa C Rohan
Journal:  AAPS J       Date:  2008-12-17       Impact factor: 4.009

8.  Unusual starch degradation pathway via cyclodextrins in the hyperthermophilic sulfate-reducing archaeon Archaeoglobus fulgidus strain 7324.

Authors:  Antje Labes; Peter Schönheit
Journal:  J Bacteriol       Date:  2007-10-05       Impact factor: 3.490

9.  Engineering of cyclodextrin glucanotransferase on the cell surface of Saccharomyces cerevisiae for improved cyclodextrin production.

Authors:  Zhankun Wang; Qingsheng Qi; Peng George Wang
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

Review 10.  Engineering of cyclodextrin glucanotransferases and the impact for biotechnological applications.

Authors:  Hans Leemhuis; Ronan M Kelly; Lubbert Dijkhuizen
Journal:  Appl Microbiol Biotechnol       Date:  2009-09-18       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.